|
TRIP11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.37316849399849E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92679205923696E-12 |
| Normal-vs-Stage2 |
2.24009999999497E-05 |
| Normal-vs-Stage3 |
1.63910000017253E-08 |
| Normal-vs-Stage4 |
1.32690000098634E-08 |
| Stage1-vs-Stage2 |
7.821600E-01 |
| Stage1-vs-Stage3 |
9.331800E-01 |
| Stage1-vs-Stage4 |
3.461600E-01 |
| Stage2-vs-Stage3 |
8.643400E-01 |
| Stage2-vs-Stage4 |
5.405800E-01 |
| Stage3-vs-Stage4 |
3.683200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78013159768398E-12 |
| Normal-vs-AfricanAmerican |
1.16869958155519E-10 |
| Normal-vs-Asian |
2.83899999997672E-06 |
| Caucasian-vs-AfricanAmerican |
7.264400E-01 |
| Caucasian-vs-Asian |
5.859800E-01 |
| AfricanAmerican-vs-Asian |
5.202000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64290803184031E-12 |
| Normal-vs-Female |
9.47239999993243E-07 |
| Male-vs-Female |
1.300140E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.26139995618269E-09 |
| Normal-vs-Extreme_Weight |
1.62980740014973E-12 |
| Normal-vs-Obese |
1.01999997337288E-09 |
| Normal-vs-Extreme_Obese |
1.93560999999232E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.331000E-01 |
| Normal_Weight-vs-Obese |
4.082200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.138000E-01 |
| Extreme_Weight-vs-Obese |
3.409500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.934400E-01 |
| Obese-vs-Extreme_Obese |
7.993800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.316110E-03 |
| Normal-vs-Age(41-60Yrs) |
4.64069893624242E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63247193540883E-12 |
| Normal-vs-Age(81-100Yrs) |
3.37790018178907E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.237800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.306580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.021900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.334400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.785600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63791202822949E-12 |
| Normal-VS-Type2 PRCC |
4.10116385296533E-13 |
| Normal-VS-KIRP CIMP |
2.798000E-02 |
| Normal-VS-Unclassified PRCC |
1.191030E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.594600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.278600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.042960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.493800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.041700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.765200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22044604925031E-16 |
| Normal-vs-N1 |
1.5356000000466E-06 |
| Normal-vs-N2 |
3.23520000000688E-06 |
| N0-vs-N1 |
7.890300E-02 |
| N0-vs-N2 |
3.587400E-01 |
| N1-vs-N2 |
1.673220E-01 |
|
|
